СОВРЕМЕННАЯ НЕИНФЕКЦИОННАЯ ЭПИДЕМИОЛОГИЯ: ФАКТОРЫ РИСКА, БРЕМЯ ЗАБОЛЕВАНИЙ И СОВРЕМЕННЫЕ ПОДХОДЫ К ПРОФИЛАКТИКЕ
- Авторы:Таджиева Нигора Убайдуллаевна, Отамуратова Наргиза Хасанджановна, Мухаммедова Севара Шахобиддиновна, Ёкубжонова Сетора Баходир кизи
- Дата публикации:November 17, 2026
- Тип:Статья
- DOI: 10.64156/mju.9975 Скопировано
- Том / № Выпуска:Том 1 №6 (2026)
Аннотация
Аннотация: В обзоре рассмотрены современные данные о бремени неинфекционных заболеваний, основных факторах риска и возможностях профилактики. Особое внимание уделено сочетанию популяционных и индивидуальных профилактических мер и применимости международных данных в странах Центральной Азии.
Цель исследования: Обобщить данные о факторах риска и бремени неинфекционных заболеваний, опубликованные в 2021–2026 гг., и оценить доказательства эффективности современных подходов к профилактике.
Материалы и методы: Выполнен аналитический обзор 20 источников, опубликованных с января 2021 г. по сентябрь 2026 г. Поиск проводили в PubMed, включая MEDLINE, с проверкой библиографических сведений в Europe PMC, Crossref и на сайтах издателей. Результаты сопоставляли с учётом дизайна исследований, изученных популяций и ограничений применимости.
Результаты: Рост абсолютного бремени неинфекционных заболеваний может сочетаться со снижением возраст-стандартизованных показателей. Поведенческие и метаболические факторы риска действуют во взаимосвязи с социальными, экологическими и коммерческими условиями. Доказательства поддерживают сочетание популяционных мер, включая регулирование табака и пищевой среды, с выявлением и контролем индивидуального риска. Эффективность вмешательств зависит от исходного риска, доступности помощи и качества внедрения.
Заключение: Профилактика неинфекционных заболеваний требует согласованной политики, укрепления первичной медицинской помощи и регулярного эпидемиологического мониторинга. Перенос международных результатов в практику стран Центральной Азии должен учитывать местные условия и доступные ресурсы.
Ключевые слова: неинфекционные заболевания; эпидемиология; факторы риска; бремя болезней; профилактика; общественное здоровье; Центральная Азия.
Annotatsiya: Sharhda yuqumli bo‘lmagan kasalliklar yuki, asosiy xavf omillari va profilaktika imkoniyatlari haqidagi zamonaviy ma’lumotlar ko‘rib chiqilgan. Aholi miqyosidagi va individual profilaktika choralarini birgalikda qo‘llashga hamda xalqaro ma’lumotlardan Markaziy Osiyo mamlakatlarida foydalanish imkoniyatlariga alohida e’tibor qaratilgan.
Tadqiqot maqsadi: 2021–2026-yillarda e’lon qilingan yuqumli bo‘lmagan kasalliklarning xavf omillari va kasalliklar yuki haqidagi ma’lumotlarni umumlashtirish hamda profilaktikaga zamonaviy yondashuvlar samaradorligiga oid dalillarni baholash.
Materiallar va usullar: 2021-yil yanvaridan 2026-yil sentabrigacha e’lon qilingan 20 ta manba asosida narrativ sharh bajarildi. Qidiruv PubMed bazasida, jumladan MEDLINE yozuvlari bo‘yicha olib borildi; bibliografik ma’lumotlar Europe PMC, Crossref va nashriyotlarning veb-saytlarida tekshirildi. Natijalar tadqiqotlar dizayni, o‘rganilgan aholi guruhlari hamda ularni amaliyotda qo‘llashga doir cheklovlarni hisobga olgan holda taqqoslandi.
Natijalar: Yuqumli bo‘lmagan kasalliklarning mutlaq yuki ortishi yosh bo‘yicha standartlashtirilgan ko‘rsatkichlarning pasayishi bilan bir vaqtda kuzatilishi mumkin. Xulq-atvorga oid va metabolik xavf omillari ijtimoiy, ekologik hamda tijoriy sharoitlar bilan o‘zaro bog‘liq holda ta’sir ko‘rsatadi. Mavjud dalillar aholi miqyosidagi choralarni, jumladan tamaki mahsulotlari va oziq-ovqat muhitini tartibga solishni, individual xavfni aniqlash va nazorat qilish bilan birgalikda qo‘llashni qo‘llab-quvvatlaydi. Profilaktik aralashuvlarning samaradorligi dastlabki xavf darajasi, tibbiy yordamdan foydalanish imkoniyati va choralarni amaliyotga joriy etish sifatiga bog‘liq.
Xulosa: Yuqumli bo‘lmagan kasalliklar profilaktikasi muvofiqlashtirilgan siyosatni, birlamchi tibbiy yordamni mustahkamlashni va muntazam epidemiologik monitoringni talab qiladi. Xalqaro tadqiqotlar natijalarini Markaziy Osiyo mamlakatlari amaliyotiga tatbiq etishda mahalliy sharoitlar va mavjud resurslar hisobga olinishi lozim.
Kalit so‘zlar: yuqumli bo‘lmagan kasalliklar; epidemiologiya; xavf omillari; kasalliklar yuki; profilaktika; jamoat salomatligi; Markaziy Osiyo.
Abstract: This review examines current evidence on the burden of noncommunicable diseases, major risk factors, and opportunities for prevention. Particular attention is given to combining population-level and individual preventive measures and to the applicability of international evidence in Central Asian countries.
Objective: To synthesize evidence on the risk factors and burden of noncommunicable diseases published in 2021–2026 and assess the evidence supporting the effectiveness of contemporary approaches to prevention.
Materials and methods: An analytical narrative review was conducted using 20 sources published between January 2021 and September 2026. Searches were performed in PubMed, including MEDLINE records, with bibliographic information verified through Europe PMC, Crossref, and publishers’ websites. Findings were compared with consideration of study designs, populations studied, and limitations affecting their applicability.
Results: An increase in the absolute burden of noncommunicable diseases may coexist with declining age-standardized rates. Behavioral and metabolic risk factors interact with social, environmental, and commercial conditions. The evidence supports combining population-level measures, including tobacco control and regulation of the food environment, with the identification and management of individual risk. The effectiveness of interventions depends on baseline risk, access to care, and implementation quality.
Conclusion: The prevention of noncommunicable diseases requires coordinated policies, stronger primary health care, and regular epidemiological monitoring. Applying international findings in Central Asian countries should account for local conditions and available resources.
Keywords: noncommunicable diseases; epidemiology; risk factors; disease burden; prevention; public health; Central Asia.
References
- 1. Богдан И. В., Горносталев М. Д., Хлынин А. П., Чистякова Д. П., Аксенова Е. И. Распространённость поведенческих и биологических факторов риска неинфекционных заболеваний среди населения Москвы // Здравоохранение Российской Федерации. – 2023. – Т. 67. – № 5. – С. 423–429. – DOI: 10.47470/0044-197X-2023-67-5-423-429.
- 2. Andreyeva T., Marple K., Marinello S., Moore T. E., Powell L. M. Outcomes Following Taxation of Sugar-Sweetened Beverages: A Systematic Review and Meta-analysis // JAMA Network Open. – 2022. – Vol. 5. – № 6. – e2215276. – DOI: 10.1001/jamanetworkopen.2022.15276.
- 3. Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis // The Lancet. – 2021. – Vol. 397. – № 10285. – P. 1625–1636. – DOI: 10.1016/s0140-6736(21)00590-0.
- 4. Bray F., Laversanne M., Sung H., Ferlay J., Siegel R. L., Soerjomataram I., Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA: A Cancer Journal for Clinicians. – 2024. – Vol. 74. – № 3. – P. 229–263. – DOI: 10.3322/caac.21834.
- 5. Clark S. N., Anenberg S. C., Brauer M. Global Burden of Disease from Environmental Factors // Annual Review of Public Health. – 2025. – Vol. 46. – № 1. – P. 233–251. – DOI: 10.1146/annurev-publhealth-071823-105338.
- 6. Dumcheva A., Laatikainen T., Rakovac I., Nevalainen J., Nuorti P. Assessing the progress in implementing population-based policies to reduce the burden of noncommunicable diseases in Eastern Europe and Central Asia, 2010-2024 // Health Policy and Planning. – 2026. – Vol. 41. – № 6. – P. 942–954. – DOI: 10.1093/heapol/czag055.
- 7. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019 // The Lancet. – 2021. – Vol. 397. – № 10292. – P. 2337–2360. – DOI: 10.1016/s0140-6736(21)01169-7.
- 8. GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 // The Lancet. – 2022. – Vol. 400. – № 10347. – P. 185–235. – DOI: 10.1016/s0140-6736(22)00847-9.
- 9. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 // The Lancet. – 2023. – Vol. 402. – № 10397. – P. 203–234. – DOI: 10.1016/s0140-6736(23)01301-6.
- 10. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 // The Lancet. – 2024. – Vol. 403. – № 10440. – P. 2162–2203. – DOI: 10.1016/s0140-6736(24)00933-4.
- 11. GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 // The Lancet. – 2025. – Vol. 406. – № 10513. – P. 1873–1922. – DOI: 10.1016/s0140-6736(25)01637-x.
- 12. Gilmore A. B., Fabbri A., Baum F., Bertscher A., Bondy K., Chang H. J. et al. Defining and conceptualising the commercial determinants of health // The Lancet. – 2023. – Vol. 401. – № 10383. – P. 1194–1213. – DOI: 10.1016/s0140-6736(23)00013-2.
- 13. Lincoff A. M., Brown-Frandsen K., Colhoun H. M., Deanfield J., Emerson S. S., Esbjerg S. et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes // The New England Journal of Medicine. – 2023. – Vol. 389. – № 24. – P. 2221–2232. – DOI: 10.1056/nejmoa2307563.
- 14. Livingston G., Huntley J., Liu K. Y., Costafreda S. G., Selbæk G., Alladi S. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission // The Lancet. – 2024. – Vol. 404. – № 10452. – P. 572–628. – DOI: 10.1016/s0140-6736(24)01296-0.
- 15. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants // The Lancet. – 2021. – Vol. 398. – № 10304. – P. 957–980. – DOI: 10.1016/s0140-6736(21)01330-1.
- 16. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults // The Lancet. – 2024. – Vol. 403. – № 10431. – P. 1027–1050. – DOI: 10.1016/s0140-6736(23)02750-2.
- 17. Neal B., Wu Y., Feng X., Zhang R., Zhang Y., Shi J. et al. Effect of Salt Substitution on Cardiovascular Events and Death // The New England Journal of Medicine. – 2021. – Vol. 385. – № 12. – P. 1067–1077. – DOI: 10.1056/nejmoa2105675.
- 18. Strain T., Flaxman S., Guthold R., Semenova E., Cowan M., Riley L. M. et al. National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022: a pooled analysis of 507 population-based surveys with 5·7 million participants // The Lancet Global Health. – 2024. – Vol. 12. – № 8. – P. e1232–e1243. – DOI: 10.1016/s2214-109x(24)00150-5.
- 19. Visseren F. L. J., Mach F., Smulders Y. M., Carballo D., Koskinas K. C., Bäck M. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice // European Heart Journal. – 2021. – Vol. 42. – № 34. – P. 3227–3337. – DOI: 10.1093/eurheartj/ehab484.
- 20. World Health Organization. Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases. – 2nd ed. – Geneva: World Health Organization, 2024. – 31 p. – ISBN 978-92-4-009107-8. – URL: https://www.who.int/publications/i/item/9789240091078.